Research areas and methodologies
Clinical research on factors predisposing to the development of the most advanced forms of chronic metabolic liver disease (MAFLD/NASH) including the search for new genetic polymorphisms and the development of new prognostic scores.
Innovative treatments for primary biliary cholangitis (PBC) and MAFLD/NASH.
Emergence of the underground in the epidemiology of chronic HCV hepatitis: scouting mini-invasive treatment of HCV positive patients in nursing homes.
Characterization and pharmacological correction of sarcopenia in patients with chronic liver disease and hepato-oncological pathology.
Noninvasive characterization of benign and malignant nodular liver disease using temporary elastometry.
Collaborations with other Research Centers
- Gothenburg University, Sweden
- Universidad de Navarra, Spain
- Magna Graecia University, Catanzaro, Italy
- University of Rome, Tor Vergata, Italy
- Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
- IRCCS Ca' Granda Foundation Ospedale Maggiore Policlinico, Milan, Italy